Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.

Al Yami MS, Silva MA, Donovan JL, Kanaan AO.

J Thromb Thrombolysis. 2017 Oct 17. doi: 10.1007/s11239-017-1562-5. [Epub ahead of print] Review.

PMID:
29043538
2.

Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.

Poudel DR, Ghimire S, Dhital R, Forman DA, Warkentin TE.

Platelets. 2017 Sep;28(6):614-620. doi: 10.1080/09537104.2017.1366973. Epub 2017 Aug 31.

PMID:
28856946
3.

Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.

Cafri G, Paxton EW, Chen Y, Cheetham CT, Gould MK, Sluggett J, Bini SA, Khatod M.

J Arthroplasty. 2017 Nov;32(11):3524-3528.e1. doi: 10.1016/j.arth.2017.05.042. Epub 2017 May 31.

PMID:
28634095
4.

Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis.

Venker BT, Ganti BR, Lin H, Lee ED, Nunley RM, Gage BF.

J Arthroplasty. 2017 Feb;32(2):645-652. doi: 10.1016/j.arth.2016.09.033. Epub 2016 Oct 5. Review.

PMID:
27823844
5.
6.

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis.

Dong WJ, Qian HJ, Qian Y, Zhou L, Hu SL.

Exp Ther Med. 2016 Aug;12(2):969-974. Epub 2016 May 18.

7.

The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.

Sartori M, Favaretto E, Migliaccio L, Guazzaloca G, Legnani C, Palareti G, Cosmi B.

Thromb Res. 2016 Mar;139:154-7. doi: 10.1016/j.thromres.2016.02.004. Epub 2016 Feb 3.

PMID:
26916314
8.

New Oral Anticoagulants in Prophylaxis of Venous Thromboembolic Disease in Major Orthopedic Surgery.

Rostagno C.

Cardiovasc Hematol Disord Drug Targets. 2016;15(3):204-9. Review.

PMID:
26721520
9.

In vitro and in vivo characterization of a reversible synthetic heparin analog.

Whelihan MF, Cooley B, Xu Y, Pawlinski R, Liu J, Key NS.

Thromb Res. 2016 Feb;138:121-129. doi: 10.1016/j.thromres.2015.12.007. Epub 2015 Dec 10.

10.

Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.

Vandiver JW, Ritz LI, Lalama JT.

J Thromb Thrombolysis. 2016 Apr;41(3):475-81. doi: 10.1007/s11239-015-1231-5. Review.

PMID:
25982217
11.

The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.

Steele KE, Canner J, Prokopowicz G, Verde F, Beselman A, Wyse R, Chen J, Streiff M, Magnuson T, Lidor A, Schweitzer M.

Surg Obes Relat Dis. 2015 May-Jun;11(3):672-83. doi: 10.1016/j.soard.2014.10.003. Epub 2014 Oct 23.

PMID:
25620436
12.

Venous thromboembolism in cancer patients.

Deng A, Galanis T, Graham MG.

Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156. Review.

PMID:
25485915
13.

A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal.

Chan NC, Siegal D, Lauw MN, Ginsberg JS, Eikelboom JW, Guyatt GH, Hirsh J.

J Thromb Thrombolysis. 2015 Aug;40(2):231-9. doi: 10.1007/s11239-014-1153-7. Review.

PMID:
25403952
14.

Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats.

Morishima Y, Kamisato C, Honda Y.

Eur J Pharmacol. 2014 Nov 5;742:15-21. doi: 10.1016/j.ejphar.2014.08.020. Epub 2014 Aug 30.

PMID:
25179572
15.

Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.

Migita K, Bito S, Nakamura M, Miyata S, Saito M, Kakizaki H, Nakayama Y, Matsusita T, Furuichi I, Sasazaki Y, Tanaka T, Yoshida M, Kaneko H, Abe I, Mine T, Ihara K, Kuratsu S, Saisho K, Miyahara H, Segata T, Nakagawa Y, Kamei M, Torigoshi T, Motokawa S.

Arthritis Res Ther. 2014 Jul 21;16(4):R154. doi: 10.1186/ar4616.

16.

Anticoagulation: choosing the optimal anticoagulant.

Hawes EM, Viera AJ.

FP Essent. 2014 Jul;422:18-23. Review.

PMID:
25033002
17.

Bemiparin, an effective and safe low molecular weight heparin: a review.

Ciccone MM, Cortese F, Corbo F, Corrales NE, Al-Momen AK, Silva A, Zito A, Pinto M, Gesualdo M, Scicchitano P.

Vascul Pharmacol. 2014 Jul;62(1):32-7. doi: 10.1016/j.vph.2014.03.001. Epub 2014 Mar 19. Review.

PMID:
24657810
18.

Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery. A systematic review.

Hull RD, Liang J, Bergqvist D, Yusen RD.

Thromb Haemost. 2014 Feb;111(2):199-212. doi: 10.1160/TH13-08-0654. Epub 2013 Oct 24. Review.

PMID:
24154501
19.

Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides.

Hirsh J, Ginsberg JS, Chan N, Guyatt G, Eikelboom JW.

Thromb Haemost. 2014 Jan;111(1):10-3. doi: 10.1160/TH13-07-0562. Epub 2013 Oct 10. Review.

PMID:
24108360
20.

Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty.

Sasaki H, Ishida K, Shibanuma N, Tei K, Tateishi H, Toda A, Yamashiro Y, Matsumoto T, Kuroda R, Kurosaka M.

Int Orthop. 2014 Mar;38(3):525-9. doi: 10.1007/s00264-013-2132-x. Epub 2013 Oct 8.

Supplemental Content

Loading ...
Support Center